This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
